Following CLD treatment, no differences in DENV midgut titers or midgut infection prevalence were observed between LP- or CLD-injected groups (Fig. 1b, Supplementary Fig. S2). Here, SLC26A3 is linked to congenital secretory chloride diarrhea 1.